Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Bosco who wrote (846)	4/3/2000 5:04:00 PM
From: david james	Read Replies (2) \| Respond to of 1298

Hopefully the single digit p/e will be a continual reminder to investors that they are in a very very comfortable financial situation. I suspect that they will tap into their ABGX shares again next year for another million shares. So they may have this p/e for a long time. It will be interesting to see what sort of late stage product they acquire. Sounds as though they want to use their cash to acquire something that is highly likely to be quite profitable in the short term, so it will probably not be gene therapy.